Literature DB >> 16283562

Outcomes for abdominoperineal resections are not worse than those of anterior resections.

Esther W L Chuwa1, Francis Seow-Choen.   

Abstract

PURPOSE: Local recurrence and cure rates following abdominoperineal resections have been reported to be much worse than sphincter-preserving anterior resections. We compared the oncologic outcomes of patients treated by abdominoperineal resections with those following sphincter-preserving anterior resections.
METHODS: The medical records of patients who underwent radical rectal resection for rectal carcinoma at the Colorectal Surgery Department, Singapore General Hospital, during the period from April 1989 to April 2002 were reviewed. A total of 791 cases were studied. Operative procedures were classified as either abdominoperineal resections or anterior resections with either straight or pouch anastomosis. Total mesorectal excision was routinely performed for carcinomas of the lower middle and lower third of the rectum. Sentinel events, including local and systemic recurrences or morbidity and mortality, were tracked prospectively.
RESULTS: There were a total of 93 abdominoperineal resections (12.1 percent), 547 anterior resections with straight anastomoses (71 percent), and 130 anterior resections with pouch anastomoses (16.9 percent). Postoperative mortality was 2.6 percent and postoperative morbidity was 13.6 percent with an overall anastomotic leakage rate of 2.5 percent. The cumulative five-year local recurrence rate was 5.4 percent for abdominoperineal resections, 3.6 percent for anterior resections with straight anastomoses, and 3.8 percent for anterior resections with pouch anastomoses (P = 0.73 by log-rank test). The median time to local recurrence also did not differ significantly between the different procedures (abdominoperineal resections, 17 months, anterior resections with straight anastomoses, 18 months, anterior resections with pouch anastomoses, 13 months). Independent predictors for local recurrence included advanced tumor stage, tumor depth, and poorly differentiated tumors. The five-year cancer-specific survival was 70 percent. The type of anastomosis did not influence disease-free survival with median disease-free survival for patients who underwent abdominoperineal resections being 100 months, survival of anterior resections with straight anastomoses being 135 months, and survival of anterior resections with pouch anastomoses being 121 months (P = 0.33 by log-rank test). The independent factors for poor survival were age greater than 65 years, advanced tumor stage, tumor depth, and poorly differentiated tumors.
CONCLUSION: Both abdominoperineal resections and sphincter-preserving anterior resections can be performed safely with low morbidity and mortality in a specialized high-volume hospital unit without compromising oncologic outcomes. With appreciation of the anatomic relations in total mesorectal excision and standardized consistent surgical technique, the oncologic outcomes of patients treated by abdominoperineal resections are not worse than those treated by sphincter-preserving anterior resections.

Entities:  

Mesh:

Year:  2006        PMID: 16283562     DOI: 10.1007/s10350-005-0227-1

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  16 in total

1.  Sphincter-preserving operations following preoperative chemoradiation: an alternative to abdominoperineal resection for lower rectal cancer?

Authors:  Jung Wook Huh; Eun Joo Jung; Yoon Ah Park; Kang Young Lee; Seung-Kook Sohn
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

2.  Oncological superiority of extralevator abdominoperineal resection over conventional abdominoperineal resection: a meta-analysis.

Authors:  Ao Huang; Hongchao Zhao; Tianlong Ling; Yingjun Quan; Minhua Zheng; Bo Feng
Journal:  Int J Colorectal Dis       Date:  2014-01-03       Impact factor: 2.571

3.  Abdominoperineal resection: how is it done and what are the results?

Authors:  W Brian Perry; J Christopher Connaughton
Journal:  Clin Colon Rectal Surg       Date:  2007-08

Review 4.  Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer--a systematic overview.

Authors:  Sigmar Stelzner; Carsta Koehler; Juliane Stelzer; Anja Sims; Helmut Witzigmann
Journal:  Int J Colorectal Dis       Date:  2011-05-21       Impact factor: 2.571

Review 5.  Short-term outcome of extra-levator abdominoperineal excision for rectal cancer.

Authors:  Sigmar Stelzner; Gunter Hellmich; Clemens Schubert; Erik Puffer; Gunter Haroske; Helmut Witzigmann
Journal:  Int J Colorectal Dis       Date:  2011-02-25       Impact factor: 2.571

6.  Factors affecting sphincter-preserving resection treatment for patients with low rectal cancer.

Authors:  Zhenqiang Sun; Xianbo Yu; Haijiang Wang; Ming Ma; Zeliang Zhao; Qisan Wang
Journal:  Exp Ther Med       Date:  2015-06-05       Impact factor: 2.447

Review 7.  Sphincter preservation for distal rectal cancer--a goal worth achieving at all costs?

Authors:  Jürgen Mulsow; Des C Winter
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

8.  Low-lying rectal cancer with anal canal involvement: abdominoperineal or low anterior resection after neoadjuvant chemoradiotherapy.

Authors:  Ly Do; Nisar Syed; Ajmel Puthawala; Samar Azawi; Imad Shbeeb; I-Yeh Gong
Journal:  Gastrointest Cancer Res       Date:  2011-05

9.  Abdominoperineal excision following preoperative radiotherapy for rectal cancer: unfavorable prognosis even with negative circumferential resection margin.

Authors:  Lin Wang; Guo-Li Gu; Zhong-Wu Li; Yi-Fan Peng; Jin Gu
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 10.  Conversations for providers caring for patients with rectal cancer: Comparison of long-term patient-centered outcomes for patients with low rectal cancer facing ostomy or sphincter-sparing surgery.

Authors:  Lisa J Herrinton; Andrea Altschuler; Carmit K McMullen; Joanna E Bulkley; Mark C Hornbrook; Virginia Sun; Christopher S Wendel; Marcia Grant; Carol M Baldwin; Wendy Demark-Wahnefried; Larissa K F Temple; Robert S Krouse
Journal:  CA Cancer J Clin       Date:  2016-03-21       Impact factor: 508.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.